Article content

CLVS Rucaparib ARIEL3

April 6, 2018 all-day
CLVS Rucaparib ARIEL3

(CLVS) Ovarian cancer patients with a BRCA-like mutation. Phase 3 data released June 20 2017, primary endpoint met. PDUFA date under priority review April 6, 2018.

Rucaparib News
The stock screener I used to find AAXN right before it jumped 179 percent

Sofi AI Market Sentiment Gauge

SOFI artificial intelligence market gauge

Picture of SOFI artificial intelligence

Market is fairly valued.